Here are Monday's biggest analyst calls of the day: Wynn, Under Armour, T-Mobile & more

Published Mon, Nov 2 20208:12 AM EST

Key Points

Morgan Stanley upgraded Wynn to overweight from equal weight.
Stifel upgraded Under Armour to buy from hold.
Atlantic Equities initiated D.R. Horton and Lennar as overweight.
Barclays upgraded McKesson to overweight from equal weight.
Piper Sandler initiated Lemonade as overweight.
Credit Suisse initiated T-Mobile as outperform.
UBS downgraded Harley-Davidson to neutral from buy.

(This story is for CNBC PRO subscribers only.) Here are the biggest calls on Wall Street on Monday: Morgan Stanley upgraded Wynn to overweight from equal weight Morgan Stanley upgraded the casino operator and said it it sees more upside and that the company was its "new favored cyclical play." "We upgrade WYNN as we see 1) an upcoming operating inflection with further upside post-COVID, 2) overblown concerns about Macau high-end, & 3) a positive catalyst if Biden wins, all at an attractive valuation. ... .WYNN our new favored cyclical play." Stifel upgraded Under Armour to buy from hold Stifel said in its upgrade of the sports equipment retailer and said it sees an "improved" balance sheet among other things for Under Armour. "We are upgrading our rating to Buy from Hold and increasing our target price to $17 from $11. Greater confidence stems from improved quality of revenue, sightlines to revenue inflection in 2021, gross margin drivers from mix and a streamlined expense base pointing to opportunity for earnings leverage." Atlantic Equities initiated D.R. Horton and Lennar as overweight Atlantic Equities initiated the homebuilders and said it sees "strong structural tailwinds" as the housing market continues on an upward trajectory. "We initiate DHI at O/W, with its high entry level exposure, decentralised company culture, manufacturing mindset and spec strategy all supporting double-digit EPS growth. Similarly, we see LEN 's technology-driven approach also driving double-digit EPS growth and initiate at O/W." Barclays upgraded McKesson to overweight from equal weight Barclays upgraded the pharmaceuticals distributor and said it believes the sector is finally close to reaching opioid litigation settlements with a majority of states. "We believe now is the time to become more constructive on the subsector, and thus we upgrade MCK and CAH on the back five key variables: generic drug pricing has served as a major headwind to the sector over the last 3-4 years, but the latest industry data shows generic drug price deflation has stabilized throughout 2020, which has alleviated earnings pressure on the sector; With passage of time, and on the back of our opioid litigation expert call on Oct 19, we believe the sector is now re